Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (PMVP)
CUSIP: 69353Y103
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common stock, par value $0.00001
- Total 13F shares
- 330,003
- Total 13F value
- $442,204
- Share change
- -30,783
- SEC-reported price per share
- $1.34
- Number of holders
- 1
- Value change
- -$41,249
- Number of sells
- 1
- Shares outstanding
- 53,394,523
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
PMVP full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Ownership snapshot
Top reported holders of PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BML Investment Partners, ...
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: BML Investment Partners, L.P.
Showing 1-6 of 15 holder rows.
Quick read
BML Investment Partners, L.P. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BML Investment Partners, L.P.'s linked filing trail.
Comparable ownership
Top 5
BML Investment Partners, L.P.
9.9%
TANG CAPITAL MANAGEMENT LLC
8.9%
Sio Capital Management, LLC
5.8%
Euclidean Capital LLC
4.9%
ArrowMark Colorado Holdings LLC
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BML Investment Partners, L.P. |
13D/G
|
9.9%
|
$6,615,000
5,292,000 shares
|
+$2,527,616 | 31 Dec 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
8.9%
|
$6,702,907
4,720,357 shares
|
$0 | 16 Sep 2025 |
| Sio Capital Management, LLC |
13D/G
13F
Company
|
5.8%
|
$3,845,725
3,076,580 shares
|
+$550,040 | 31 Mar 2026 |
| Euclidean Capital LLC |
13D/G
3/4/5
13F
10%+ Owner · Company
|
4.9%
|
$3,284,554
2,627,643 shares
|
$0 | 31 Mar 2026 |
| ArrowMark Colorado Holdings LLC |
13F
13D/G
Company
|
3.7%
from 13D/G
|
$3,562,227
2,872,764 shares
|
— | 31 Mar 2026 |
| ORBIMED ADVISORS LLC |
3/4/5
10%+ Owner
|
9.3%
|
$7,562,442
4,975,291 shares
|
-$2,420,000 | 23 Oct 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
330,003
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
69
Q2 2026 holders
1
Holder diff
-68
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend